Valuation Multiples · Medical Equipment Supplier

Medical Equipment Supplier EBITDA Multiples: 3.5x–6.0x — What Buyers Pay (2026)

What buyers are paying for DME and medical supply businesses in the $1M–$5M revenue range — and what drives valuations up or down.

Medical equipment suppliers in the lower middle market typically trade at 3.5x–6x EBITDA, depending on revenue quality, regulatory standing, and customer diversification. Businesses with strong recurring rental income, active DMEPOS accreditation, and clean Medicare billing histories command premium multiples. Owner-dependent businesses with reimbursement risk or compliance exposure trade at the lower end.

Medical Equipment Supplier EBITDA Multiples (2026)

Practice SizeEBITDA RangeMultiple RangeNotes
Entry-Level$300K–$500K3.5x–4.0xOwner-dependent referrals, limited recurring revenue, minimal documentation, or unresolved compliance exposure.
Core Market$500K–$750K4.0x–4.75xEstablished DMEPOS accreditation, moderate recurring revenue mix, some customer concentration present.
Quality Business$750K–$1.25M4.75x–5.5xDiversified payer mix, strong rental and service contract revenue, documented management team, clean billing history.
Premium Asset$1.25M+5.5x–6.0xExclusive supplier agreements, high recurring revenue, transferable Medicare numbers, and no key-person dependency.

Valuation Drivers — What Makes Your Multiple Higher or Lower

The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.

Recurring Revenue Mix

High Positive

Businesses deriving 50%+ of revenue from equipment rentals and service contracts command materially higher multiples than those reliant on one-time equipment sales.

DMEPOS Accreditation and Medicare Standing

High Positive

Active accreditation and clean Medicare/Medicaid billing history reduce buyer risk and support premium pricing; pending audits or overpayment demands are significant value killers.

Customer and Referral Concentration

High Negative

Single hospital system or physician group exceeding 25% of revenue creates deal risk; buyers apply valuation discounts or demand earnouts to mitigate concentration exposure.

Supplier and Distribution Agreements

Moderate Positive

Exclusive or preferred agreements with national medical brands that are transferable to a new owner add defensible competitive moat and support higher exit multiples.

Owner Dependency

High Negative

Businesses where the founder controls key referral relationships or payer approvals face multiple compression; documented SOPs and tenured staff offset this risk significantly.

Recent Market Trends

CMS reimbursement pressure and competitive bidding changes have made buyers increasingly selective about payer mix. PE-backed roll-up activity in home medical equipment has elevated multiples for accredited platforms with recurring revenue. SBA financing remains broadly available for qualified buyers, sustaining strong deal flow in the $1M–$4M transaction range.

Who Buys Medical Equipment Suppliers in 2026

Individual Operator / Search Fund

Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators

3.5x–4.5x EBITDA

What they want: Stable, transferable cash flow in a Medical Equipment Supplier. SBA-eligible business, strong recurring revenue mix, and a seller available for a 12–18 month transition.

Pros for seller

  • +SBA 7(a) financing means 10% buyer equity — faster than waiting for institutional capital
  • +Buyer works inside the business, maintaining client and staff relationships
  • +Deal structure is typically straightforward: cash at close plus seller note

Cons for seller

  • Lower multiples than PE buyers — typically at the low-to-mid end of the range
  • Requires meaningful seller involvement post-close for transition
  • SBA approval timeline adds 60–90 days to closing

PE-Backed Roll-Up Platform

Private equity consolidators building a Medical Equipment Supplier portfolio, regional or national platforms

4.2x–5.4x EBITDA

What they want: Scale, operational quality, and geographic coverage. Strong recurring revenue mix with minimal customer and referral concentration. Clean financials, documented systems, and staff who can operate without the selling owner.

Pros for seller

  • +All-cash close with no SBA financing contingency or approval delay
  • +Highest multiples available for premium businesses
  • +Equity rollover option — seller keeps 10–30% stake and participates in platform exit

Cons for seller

  • Extensive 90–150 day due diligence process
  • Post-close integration into a larger platform changes operating culture
  • Usually requires seller to remain in a leadership role for 12–24 months

Strategic Acquirer

Larger Medical Equipment Supplier operators, adjacent-industry buyers adding capacity or geography

4.9x–6x EBITDA

What they want: Client relationships, staff, and market position that complement existing operations. Recurring Revenue Mix is especially valuable when it fills a gap the buyer cannot build organically.

Pros for seller

  • +Can pay above-model multiples for strong strategic fit
  • +Buyer already understands the business — diligence moves faster
  • +Shorter transition requirement when operational overlap exists

Cons for seller

  • Fewer competing buyers — less negotiating leverage
  • Non-compete scope is typically broader than PE or individual deals
  • Operations and brand may change significantly post-close

Sample Medical Equipment Supplier Transactions

Midwest home medical equipment supplier with DMEPOS accreditation, 60% rental revenue, diversified referral base of 40+ physicians, and clean Medicare history.

$620K

EBITDA

4.8x

Multiple

$2.98M

Price

Southeast surgical supply distributor with exclusive regional distribution agreement, $2.1M recurring service contract revenue, and tenured five-person operations team.

$1.1M

EBITDA

5.5x

Multiple

$6.05M

Price

Northeast DME company with owner-dependent physician referrals, moderate Medicare audit exposure, and 70% one-time equipment sales revenue mix.

$410K

EBITDA

3.7x

Multiple

$1.52M

Price

EBITDA Valuation Estimator

Get your Medical Equipment Supplier business value range instantly

$

Industry: Medical Equipment Supplier · Multiples based on 4.0x–4.75x (Core Market)

Powered by DealFlow OS

dealflow-os.com · Free M&A tools for every stage of the deal

QR code — dealflow-os.com

How to Use These Multiples

For Sellers: 4-Step Valuation Walkthrough

  1. 1

    Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.

  2. 2

    Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.

  3. 3

    Address your customer and referral concentration before going to market — this is the most common reason Medical Equipment Supplier businesses receive offers at the low end of the 3.5x–6x range. Buyers identify it in diligence and reprice accordingly.

  4. 4

    Quantify and document your recurring revenue mix with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.

For Buyers: Validate the Asking Multiple

  1. 1

    Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Medical Equipment Supplier seller cannot produce reconciled financials, that signals what the full diligence process will look like.

  2. 2

    Verify the recurring revenue mix claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Medical Equipment Supplier is worth 6x or 3.5x.

  3. 3

    Assess customer and referral concentration directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.

  4. 4

    Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.

Frequently Asked Questions

What EBITDA multiple should I expect when selling my medical equipment supply business?

Most lower middle market DME businesses sell at 3.5x–6x EBITDA. Recurring rental revenue, clean compliance history, and diversified customers push multiples toward the higher end.

How does Medicare and Medicaid reimbursement risk affect my business valuation?

Buyers heavily scrutinize billing compliance and payer mix. Pending audits, high denial rates, or CMS exposure can reduce your multiple by 0.5x–1.5x or trigger earnout structures.

Can I use an SBA loan to acquire a medical equipment supplier?

Yes. SBA 7(a) loans are commonly used for DME acquisitions meeting $300K+ EBITDA thresholds. Buyers typically inject 10–20% equity with a seller note bridging any valuation gap.

What is the most important thing I can do to maximize my exit valuation?

Build documented recurring revenue through rentals and service contracts, ensure DMEPOS accreditation is current and transferable, and reduce owner dependency before going to market.

More Medical Equipment Supplier Guides

Related Reading

Find Medical Equipment Supplier businesses at the right price

DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.

No credit card required